Clinical trial

Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps

NCT01732536 · Intersect ENT, Industry · Completed

Key facts

NCT number NCT01732536
Title Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps
Official title A Clinical Evaluation of the Safety and Efficacy of the Steroid-Releasing S8 Sinus Implant Used in Post-Sinus Surgery Patients With Recurrent Sinus Obstruction
Acronym RESOLVE
Lead sponsor Intersect ENT, Industry
Status Completed
Phase Phase 2/Phase 3
Study type Interventional
Conditions Chronic Sinusitis, Nasal Polyps
Intervention type Drug, Procedure
Interventions S8 Sinus Implant, Sham procedure, Mometasone furoate nasal spray
Enrollment 100
Start date Jan 1, 2013
Primary completion Nov 1, 2013
Completion May 1, 2014
First posted Nov 26, 2012
Last update posted Jul 20, 2018
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies